FDA.reportPublic FDA data

HYPROMELLOSE 2910 (5 MPA.S)

Substance profile for UNII R75537T0T4, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
R75537T0T4
Preferred term
HYPROMELLOSE 2910 (5 MPA.S)
Registry number
9004-65-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1300452
PubChem
0
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1300452mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1300452
FDA Substance Registration SystemR75537T0T4precision.fda.gov/uniisearch/srs/unii/R75537T0T4

DailyMed Socrata Ingredients#

Ingredient, DailyMed label, SPL version table
IngredientDailyMed labelSPL version
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. SIMVASTATIN Tablets USP for oral use Initial U.S. Approval: 19911
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use ciprofloxacin safely and effectively. See full prescribing information for ciprofloxacin. CIPROFLOXACIN tablets USP, for oral use Initial U.S. Approval: 19871
HYPROMELLOSE 2910 (5 MPA.S)AMOXICILLIN AND CLAVULANATE POTASSIUM1
HYPROMELLOSE 2910 (5 MPA.S)ETODOLAC3
HYPROMELLOSE 2910 (5 MPA.S)Metformin Hydrochloride Tablets USP Rx Only3
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN Tablet, Film Coated for Oral use Initial U.S. Approval: 19969
HYPROMELLOSE 2910 (5 MPA.S)NABUMETONE2
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use Tacrolimus Capsules USP safely and effectively. See full prescribing information for Tacrolimus Capsules USP. Tacrolimus Capsules USP Initial U.S. Approval 1994 Rx Only9
HYPROMELLOSE 2910 (5 MPA.S)QUETIAPINE FUMARATE1
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use Nebivolol safely and effectively. see full prescribing information for Nebivolol. Nebivolol (Nebivolol) TABLET for ORAL use. Initial U.S. Approval: 2007 These highlights do not include all the information needed to use Nebivolol safely and effectively.see full prescribing information for Nebivolol Nebivolol (Nebivolol) TABLET for ORAL use. Initial U.S. Approval:20073
HYPROMELLOSE 2910 (5 MPA.S)Metformin Hydrochloride Tablets USP Rx Only4
HYPROMELLOSE 2910 (5 MPA.S)METFORMIN HYDROCHLORIDE TABLETS USP, 500 mg, 850 mg, and 1000 mg 1048 1049 7214 Rx only2
HYPROMELLOSE 2910 (5 MPA.S)METFORMIN HYDROCHLORIDE TABLETS USP, 500 mg, 850 mg, and 1000 mg 1048 1049 7214 Rx only1
HYPROMELLOSE 2910 (5 MPA.S)Morphine Sulfate Extended-release Capsules, USP Revised: May 2011 CII Rx only 1985282
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use carvedilol safely and effectively.See full prescribing information for carvedilol. Carvedilol Tablets, USP Initial U.S. Approval: 19951
HYPROMELLOSE 2910 (5 MPA.S)Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP1
HYPROMELLOSE 2910 (5 MPA.S)Metformin Hydrochloride Tablets USP Rx Only1
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use clopidogrel tablets safely and effectively. See full prescribing information for clopidogrel tablets. Clopidogrel Tablets USP for oral use Initial U.S. Approval: 19971
HYPROMELLOSE 2910 (5 MPA.S)d1b30723-e2b1-4772-a11e-57ba9acc93432
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. Simvastatin Tablets USP for oral use Initial U.S. Approval: 19914
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. Simvastatin Tablets USP for oral use Initial U.S. Approval: 19911
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951001
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN Tablet, Film Coated for Oral use Initial U.S. Approval: 19961
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use amoxicillin safely and effectively. See full prescribing information for amoxicillin. Amoxicillin Capsules, Tablets, and Powder for Oral Suspension Initial U.S. Approval: 1974 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and other antibacterial drugs, amoxicillin should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.3
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use quetiapine fumarate tablets safely and effectively. See full prescribing information for quetiapine fumarate tablets. Quetiapine Fumarate Tablets, for oral use Initial U.S. Approval: 19975
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 19921
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN Tablet, Film Coated for Oral use Initial U.S. Approval: 19967
HYPROMELLOSE 2910 (5 MPA.S)71901b84-5ce2-420c-bb86-c44479fc156c4
HYPROMELLOSE 2910 (5 MPA.S)34b1ac49-9386-47cc-b078-f9e0415309796
HYPROMELLOSE 2910 (5 MPA.S)0a3777cf-5539-4b19-9964-149d9ca0ab2c5
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use Renagel safely and effectively. See full prescribing information for Renagel. Renagel (sevelamer hydrochloride) Tablet for Oral use Initial U.S. Approval: 20001
HYPROMELLOSE 2910 (5 MPA.S)f55098b4-e653-4929-8ea6-10c933249eb12
HYPROMELLOSE 2910 (5 MPA.S)8aedeb67-c3ad-460a-975e-e1b3e3cafd272
HYPROMELLOSE 2910 (5 MPA.S)011d6e48-f009-4644-90bb-7d9d94b9e9282
HYPROMELLOSE 2910 (5 MPA.S)Metformin Hydrochloride Tablets, USP2
HYPROMELLOSE 2910 (5 MPA.S)489c5c7d-75e3-4b98-b7d5-3c61e2f98adf2
HYPROMELLOSE 2910 (5 MPA.S)4213db46-f17e-48f5-aa18-114b2b8143701
HYPROMELLOSE 2910 (5 MPA.S)Metformin Hydrochloride Tablets USP3
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951
HYPROMELLOSE 2910 (5 MPA.S)Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP2
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use amoxicillin safely and effectively. See full prescribing information for amoxicillin. Amoxicillin Capsules, Tablets, and Powder for Oral Suspension Initial U.S. Approval: 1974 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and other antibacterial drugs, amoxicillin should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.1
HYPROMELLOSE 2910 (5 MPA.S)FACTIVE ® (gemifloxacin mesylate) Tablets1
HYPROMELLOSE 2910 (5 MPA.S)Diltiazem Hydrochloride Extended-Release Capsules, USP [Once-a-Day Dosage]1
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use carvedilol tablets USP safely and effectively. See full prescribing information for Carvedilol Tablets USP. Initial U.S. Approval: 19951
HYPROMELLOSE 2910 (5 MPA.S)METFORMIN HYDROCHLORIDE TABLETS USP, 500 mg Rx only1
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951
HYPROMELLOSE 2910 (5 MPA.S)Ciprofloxacin Tablets, USP1
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use levocetirizine dihydrochloride tablets safely and effectively. See full prescribing information for levocetirizine dihydrochloride tablets. LEVOCETIRIZINE dihydrochloride tablets for oral use Initial U.S. Approval: 19951
HYDROXYPROPYL METHYLCELLULOSE E5 [II]2efa5aa8-9b72-4b3f-968e-3f11425ebdae1
HYDROXYPROPYL METHYLCELLULOSE E5 [II]fa34818a-cb02-4ec9-b84b-cf18e1045e742
HYPROMELLOSE 2910 (5 MPA.S)1bc5a105-530b-4f62-95a7-717ce03f6b021
HYPROMELLOSE 2910 (5 MPA.S)baf55093-19b1-4f94-a51c-85bc2e80fd2c1
HYPROMELLOSE 2910 (5 MPA.S)6f5962de-3182-4690-b9c0-716da498abe21
HYPROMELLOSE 2910 (5 MPA.S)d59bf418-59c4-4cf3-839b-c794e38f10831
HYDROXYPROPYL METHYLCELLULOSE E5 [II]0df380e9-98be-4a09-a3e7-ab64f920692f2
HYDROXYPROPYL METHYLCELLULOSE E5 [II]c5539569-063f-4ab1-8a86-63ece30373bf2
HYDROXYPROPYL METHYLCELLULOSE E5 [II]c9e714f2-b536-4bc2-a27a-6f9e8f931ad32
HYDROXYPROPYL METHYLCELLULOSE E5 [II]9a277e3e-dd0c-4c88-a2d3-ae27fb19041e5
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use EXALGO ® safely and effectively. See full prescribing information for EXALGO. EXALGO (hydromorphone HCl) Extended-Release Tablets, for oral use, CII Initial U.S. Approval: 19841
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951000
HYPROMELLOSE 2910 (5 MPA.S)Citalopram Tablets USP1
HYPROMELLOSE 2910 (5 MPA.S)Citalopram Tablets USP1
HYPROMELLOSE 2910 (5 MPA.S)Citalopram Tablets USP1
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use Renagel safely and effectively. See full prescribing information for Renagel. Renagel (sevelamer hydrochloride) Tablet for Oral use Initial U.S. Approval: 20003
HYDROXYPROPYL METHYLCELLULOSE E5 [II]3bebaa59-ef09-472b-af92-ec6b135898492
HYDROXYPROPYL METHYLCELLULOSE E5 [II]e9537bbe-e63b-4440-af70-5d32853ecf1f2
HYDROXYPROPYL METHYLCELLULOSE E5 [II]0642f4f2-d3ae-4c8d-b8d3-585681638e931
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use carvedilol tablets USP safely and effectively. See full prescribing information for carvedilol tablets USP. CARVEDILOL tablets USP for oral use Initial U.S. Approval: 19951
HYDROXYPROPYL METHYLCELLULOSE E5 [II]CETAFEN EXTRA1
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 19923
HYPROMELLOSE 2910 (5 MPA.S)Cefprozil Tablets USP, 250 mg and 500 mg1
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use bicalutamide safely and effectively. See full prescribing information for bicalutamide. Bicalutamide Tablets USP for Oral use Initial U.S. Approval : 19951
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use clopidogrel tablets safely and effectively. See full prescribing information for clopidogrel tablets. Clopidogrel Tablets USP Initial U.S. Approval: 19972
HYPROMELLOSE 2910 (5 MPA.S)d54a97d5-3664-4ca5-bffd-8366c7255b738
HYPROMELLOSE 2910 (5 MPA.S)Metformin Hydrochloride Tablets USP Rx Only2
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use quetiapine fumarate tablets safely and effectively. See full prescribing information for quetiapine fumarate tablets. Quetiapine Fumarate Tablets Initial U.S. Approval: 199 72
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use donepezil hydrochloride tablets safely and effectively. See full prescribing information for donepezil hydrochloride tablets. Donepezil Hydrochloride Tablets Initial U.S. Approval: 19964
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951
HYPROMELLOSE 2910 (5 MPA.S)Citalopram Tablets, USP5
HYPROMELLOSE 2910 (5 MPA.S)Amoxicillin Capsules, Tablets and Powder for Oral Suspension, USP6
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use Zolpidem Tartrate Tablets, USP safely and effectively. See full prescribing information for Zolpidem Tartrate Tablets, USP. Zolpidem Tartrate Tablets, USP - CIV Initial U.S. Approval: 19927
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19953
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use EXALGO™ safely and effectively. See full prescribing information for EXALGO. EXALGO (hydromorphone HCl) Extended-Release Tablets, CII Initial U.S. Approval: 19841
Hypromellose 2910 (5 MPA.S)8a023942-01e8-4849-aa3c-1a640ffc7fd37
HYPROMELLOSE 2910 (5 MPA.S)Bisoprolol Fumarate Tablets USP2
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use carvedilol tablets USP safely and effectively. See full prescribing information for carvedilol tablets USP. CARVEDILOL tablets USP for oral use Initial U.S. Approval: 19951
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 19921
HYPROMELLOSE 2910 (5 MPA.S)Bisacodyl USP 5 mg Laxative3
HYPROMELLOSE 2910 (5 MPA.S)CIPROFLOXACIN TABLETS, USP1
HYPROMELLOSE 2910 (5 MPA.S)Ciproflaxin Tablets1
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19952
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP for Oral Use Initial U.S. Approval: 19923
HYPROMELLOSE 2910 (5 MPA.S)3e463126-78a9-4ec5-904c-0424a64d8ae81
HYPROMELLOSE 2910 (5 MPA.S)ASPIRIN ENTERIC COATED ORANGE TABLETS, 325 mg1
HYPROMELLOSE 2910 (5 MPA.S)ACETAMINOPHEN CAPLETS, 500 mg2
HYPROMELLOSE 2910 (5 MPA.S)9dac97a5-c992-4601-af93-138bfe2302a81
HYPROMELLOSE 2910 (5 MPA.S)These highlights do not include all the information needed to use zolpidem tartrate safely and effectively. See full prescribing information for zolpidem tartrate tablets. Zolpidem Tartrate Tablets CIV Initial U.S. Approval: 19921
HYPROMELLOSE 2910 (5 MPA.S)Bisoprolol Fumarate Tablets USP1
HYPROMELLOSE 2910 (5 CPS)CIPROFLOXACIN TABLETS, USP1
HYPROMELLOSE 2910 (5 CPS)CIPROFLOXACIN TABLETS, USP1
HYPROMELLOSE 2910 (5 MPA.S)88f1abdc-f53e-4ff9-b4c1-3cfbc2609b791
HYPROMELLOSE 2910 (5 CPS)Metformin Hydrochloride Tablets, USP1
HYPROMELLOSE 2910 (5 MPA.S)Losartan Potassium Tablets USP 25 mg, 50 mg and 100 mg1000
HYPROMELLOSE 2910 (5 CPS)These highlights do not include all the information needed to use Ranexa safely and effectively. See full prescribing information for Ranexa. Ranexa (ranolazine) extended-release tablets Initial U.S. Approval: 20062
HYPROMELLOSE 2910 (5 MPA.S)TAMOXIFEN CITRATE TABLETS USP, 10 mg and 20 mg (base) 0784 0782 Rx only2
HYPROMELLOSE 2910 (5 MPA.S)METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3282
HYPROMELLOSE 2910 (5 MPA.S)ONDANSETRON HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3071
HYPROMELLOSE 2910 (5 MPA.S)QUETIAPINE FUMARATE TABLET, FILM COATED [BRYANT RANCH PREPACK]1003
HYPROMELLOSE 2910 (5 MPA.S)ANASTROZOLE TABLET [BRYANT RANCH PREPACK]1001
HYPROMELLOSE 2910 (5 MPA.S)BICALUTAMIDE TABLET [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (5 MPA.S)BISOPROLOL FUMARATE TABLET [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (5 MPA.S)IRBESARTAN (IRBESARTAN ) TABLET [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (5 MPA.S)LAMIVUDINE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (5 MPA.S)TACROLIMUS CAPSULE, GELATIN COATED [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (5 MPA.S)VALSARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (5 MPA.S)VALSARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (5 MPA.S)EXALGO (HYDROMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [MALLINCKRODT, INC]36
HYPROMELLOSE 2910 (5 MPA.S)CITALOPRAM TABLET, FILM COATED [INTERNATIONAL LABORATORIES, INC.]31
HYPROMELLOSE 2910 (5 MPA.S)PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) GRANULE, DELAYED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]26
HYPROMELLOSE 2910 (5 MPA.S)CIPROFLOXACIN TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]19

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII R75537T0T4 page 1 of 1 · 23 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653GUM, CHEWINGBUCCAL336 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653TABLETBUCCAL5 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653POWDERNASALNA
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653SPRAYNASAL1 mg/1ml
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653SPRAY, METEREDNASAL1 mg/1ml
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653CAPSULEORAL930 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653CAPSULE, DELAYED RELEASEORAL563 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653CAPSULE, EXTENDED RELEASEORAL1508 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653FILM, SOLUBLEORAL201 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653POWDER, FOR SUSPENSIONORAL2940 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653SUSPENSIONORAL975 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653SUSPENSION, EXTENDED RELEASEORAL727 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653SYRUPORAL200 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653TABLETORAL1200 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653TABLET, CHEWABLEORAL120 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653TABLET, COATEDORAL24 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653TABLET, DELAYED RELEASEORAL103 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653TABLET, EXTENDED RELEASEORAL670 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653TABLET, FILM COATEDORAL264 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653TABLET, FILM COATED, EXTENDED RELEASEORAL107 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653TABLET, FOR SUSPENSIONORAL76 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653TABLET, ORALLY DISINTEGRATINGORAL25 mg
HYPROMELLOSE 2910 (5 MPA.S)R75537T0T49004653FILMSUBLINGUAL4.68 mg